Ablynx Competitors and Similar CompaniesClear all
Ablynx's competitors and similar companies include ImmunoGen.
 Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | |
Founding Date | Founding Date 2001 | Founding Date 1981 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Gent, BE HQ | Locations Waltham, US HQ |
Employees | Employees 1252% decrease | Employees 277161% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) $108.8m (FY, 2022) |
Net income | Net income (€1.1m) (FY, 2016) | Net income ($222.9m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company